Otsuka’s
FighTBack Strategy:
Collaboration

Otsuka is proud to collaborate with leading academic and non-profit research institutions and other private companies on truly paradigm-shifting technologies.

Otsuka is a proud member of the Project to Accelerate New Treatments for Tuberculosis (PAN-TB Collaboration). It is a consortium of philanthropic, non-profit and private sector organisations who aim to create treatment regimens for TB patients that is effective, no matter their drug resistance status.

Otsuka also participates in the EU-Pearl Project. The objective is to revolutionise the way clinical trials are conducted, by making them more efficient (and therefore quicker) and more patient-friendly.